Search
CN
About us
Our Company
Our Culture
Our History
Pipeline
Therapy
Product&Pipeline
Medicines
Health care
R&D
Complex Product and Platform
Innovative Medicines
Medical Devices
Technical Services(CDMO/CMO)
Partnering
Internationalization
R&D
One-stop service
Provide what you want
News
Press releases
Careers
Join us
Our Employees
Incentives
Opportunities
Investors
Investor contact
Contact us
CN
Home
About us
Our Company
Our Culture
Our History
Pipeline
Therapy
Product&Pipeline
Medicines
Health care
R&D
Complex Product and Platform
Innovative Medicines
Medical Devices
Technical Services(CDMO/CMO)
Partnering
Internationalization
R&D
One-stop service
Provide what you want
News
Press releases
Careers
Join us
Our Employees
Incentives
Opportunities
Investors
Investor contact
Contact us
Home
·
News
·
Press releases
·
Press releases
SCROLL DOWN
Press releases
Announcement of the receipt of the listing notice to Changfeng Pharmaceutical Co. Ltd.
Jul.25.2022
1667
Share
Back to list
Previous chapter
Good news from CF PharmTech | The first domestic blockbuster product for the treatment of allergic rhinitis - Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Sufiemin ®) was approved
Next chapter
CF PharmTech has completed F round of 360 million yuan equity investment to support rapid development of domestic high-end inhalation products.
About us
Our Company
Our Culture
Our History
Pipeline
Therapy
Product&Pipeline
Medicines
Health care
R&D
Complex Product and Platform
Innovative Medicines
Medical Devices
Technical Services(CDMO/CMO)
Partnering
Internationalization
R&D
One-stop service
Provide what you want
News
Press releases
Careers
Join us
Our Employees
Incentives
Opportunities
Investors
Investor contact
Contact us
迈博体育(中国)股份有限公司
|
老葡萄京官网(中国)有限责任公司官网
|
忆博竞技(中国)有限公司
|
博乐体育（中国）博乐有限责任公司
|
江南电竞游戏(中国)有限公司
|
fh凤凰体育首页(中国)官方网站
|
aoa体育|中国有限公司官网
|
BR88冠亚官网(中国)有限公司官网
|
立博电竞官网|湖南科技有限公司
|
